NIGHTHAWK THERAPEUTICS
DEAD

Serial Number

97200468

Owner

Osprey Biopharmaceuticals, Inc.

Attorney

John Paul Oleksiuk

Filing Date

Jan 3, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NIGHTHAWK THERAPEUTICS Trademark

Serial Number: 97200468

NIGHTHAWK THERAPEUTICS is a trademark filed by Osprey Biopharmaceuticals, Inc. on January 3, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Osprey Biopharmaceuticals, Inc. (2 trademarks)

6175 Nancy Ridge Drive
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

January 3, 2022

Registration Date

Not Registered

Goods & Services

Pharmaceutical agents for the treatment and prevention of autoimmune, inflammatory, musculoskeletal, oncological, ophthalmic, and metabolic diseases, and cancer

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 24, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 24, 2025 ABN2
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 24, 2025 ZZZX
WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
Feb 24, 2025 PBSR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 19, 2025 CNSA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 31, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 31, 2024 GNRT
NON-FINAL ACTION WRITTEN
Oct 31, 2024 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 30, 2024 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 16, 2023 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 30, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 30, 2023 GNSL
SUSPENSION LETTER WRITTEN
Mar 30, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 25, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 24, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 7, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 7, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 7, 2022 CNRT
ASSIGNED TO EXAMINER
Oct 6, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 6, 2022 NWOS
NEW APPLICATION ENTERED
Jan 6, 2022 NWAP